Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 482,500
-26,500 (-5.21%)
Last updated: Aug 31, 2026, 1:54 PM KST
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 6.46 trillion as of August 31, 2026. Its market cap has increased by 69.79% in one year.
Market Cap
6.46T
Enterprise Value
6.65T
Revenue
1.66T
Ranking
n/a
PE Ratio
29.77
Stock Price
482,500.00
ChartMarket Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 6.46T, an increase of 848.84%. That is a compound annual growth rate of 15.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 6.46T | 12.69% |
| Dec 30, 2025 | 5.73T | 61.14% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 6.33T |
| Hanall Biopharma | 3.28T |
| Celltrion Pharm | 1.88T |
| GC Biopharma | 1.49T |
| Daewoong Pharmaceutical | 1.48T |
| Chong Kun Dang Pharmaceutical | 902.56B |
| Boryung | 766.24B |
| Daewoong | 756.24B |